Paraoxonase Role in Human Neurodegenerative Diseases

被引:36
作者
Reichert, Cadiele Oliana [1 ]
Levy, Debora [1 ]
Bydlowski, Sergio P. [1 ,2 ]
机构
[1] Univ Sao Paulo, Hosp Clin HCFMUSP, Lipids Oxidat & Cell Biol Grp, Lab Immunol LIM19,Heart Inst InCor,Fac Med, BR-05403900 Sao Paulo, Brazil
[2] CNPq, Inst Nacl Ciencia & Tecnol Med Regenerat INCT Reg, BR-21941902 Rio De Janeiro, Brazil
关键词
paraoxonases; oxidative stress; multiple sclerosis; amyotrophic lateral sclerosis; Alzheimer’ s disease; Parkinson’ ONSET ALZHEIMERS-DISEASE; PROGRESSIVE MULTIPLE-SCLEROSIS; AMYOTROPHIC-LATERAL-SCLEROSIS; MILD COGNITIVE IMPAIRMENT; PON1 GENE POLYMORPHISMS; PARKINSONS-DISEASE; ARYLESTERASE ACTIVITY; CEREBROSPINAL-FLUID; SERUM PARAOXONASE; OXIDATIVE STRESS;
D O I
10.3390/antiox10010011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human body has biological redox systems capable of preventing or mitigating the damage caused by increased oxidative stress throughout life. One of them are the paraoxonase (PON) enzymes. The PONs genetic cluster is made up of three members (PON1, PON2, PON3) that share a structural homology, located adjacent to chromosome seven. The most studied enzyme is PON1, which is associated with high density lipoprotein (HDL), having paraoxonase, arylesterase and lactonase activities. Due to these characteristics, the enzyme PON1 has been associated with the development of neurodegenerative diseases. Here we update the knowledge about the association of PON enzymes and their polymorphisms and the development of multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD) and Parkinson's disease (PD).
引用
收藏
页码:1 / 26
页数:26
相关论文
共 258 条
[1]   The Role of PON1 Variants in Disease Susceptibility in a Turkish Population [J].
Abudayyak, Mahmoud ;
Boran, Tugce ;
Tukel, Rumeysa ;
Oztas, Ezgi ;
Ozhan, Gul .
GLOBAL MEDICAL GENETICS, 2020, 7 (02) :41-46
[2]   Gin → Arg 191 polymorphism of paraoxonase and Parkinson's disease [J].
Akhmedova, S ;
Anisimov, S ;
Yakimovsky, A ;
Schwartz, E .
HUMAN HEREDITY, 1999, 49 (03) :178-180
[3]   Paraoxonase 1 Met-Leu 54 polymorphism is associated with Parkinson's disease [J].
Akhmedova, SN ;
Yakimovsky, AK ;
Schwartz, EI .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2001, 184 (02) :179-182
[4]   Synergistic Epistasis of Paraoxonase 1 (rs662 and rs85460) and Apolipoprotein E4 Genes in Pathogenesis of Alzheimer's Disease and Vascular Dementia [J].
Alam, Rizwan ;
Tripathi, Manjari ;
Mansoori, Nasim ;
Parveen, Shama ;
Luthra, Kalpana ;
Lakshmy, Ramakrishnan ;
Sharma, Subhadra ;
Arulselvi, Subramanian ;
Mukhopadhyay, Asok K. .
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2014, 29 (08) :769-776
[5]  
Alzheimers Association, 2015, Alzheimers Dement, V11, P332
[6]   Role of paraoxonase 1 (PON1) in organophosphate metabolism: Implications in neurodegenerative diseases [J].
Androutsopoulos, Vasilis P. ;
Kanavouras, Konstantinos ;
Tsatsakis, Aristidis M. .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2011, 256 (03) :418-424
[7]  
[Anonymous], 2017, Global action plan on the public health response to dementia-2017-2025
[8]   Effect of radiotherapy on activity and concentration of serum paraoxonase-1 in breast cancer patients [J].
Arenas, Meritxell ;
Garcia-Heredia, Anabel ;
Cabre, Noemi ;
Luciano-Mateo, Fedra ;
Hernandez-Aguilera, Anna ;
Sabater, Sebastia ;
Bonet, Marta ;
Gascon, Marina ;
Fernandez-Arroyo, Salvador ;
Fort-Gallifa, Isabel ;
Camps, Jordi ;
Joven, Jorge .
PLOS ONE, 2017, 12 (11)
[9]   The relationship between serum paraoxonase levels and carotid atherosclerotic plaque formation in Alzheimer's patients [J].
Arslan, Ayse ;
Tuzun, Fatma Aykan ;
Arslan, Harun ;
Demir, Halit ;
Tamer, Sibel ;
Demir, Canan ;
Tasin, Muhterem .
NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2016, 50 (06) :403-409
[10]   Dysfunctional High-density Lipoprotein: The Role of Myeloperoxidase and Paraoxonase-1 [J].
Bacchetti, Tiziana ;
Ferretti, Gianna ;
Carbone, Federico ;
Ministrini, Stefano ;
Montecucco, Fabrizio ;
Jamialahmadi, Tannaz ;
Sahebkar, Amirhossein .
CURRENT MEDICINAL CHEMISTRY, 2021, 28 (14) :2842-2850